Patients who have received any continuous or intermittent small molecule therapeutics (excluding monoclonal antibodies) =<  effective half-lives prior to registration or who have not recovered from side effects of such therapy
Patients who have received any continuous or intermittent small molecule therapeutics (excluding monoclonal antibodies) =<  effective half lives prior to starting study drug or who have not recovered from side effects of such therapy
Patients who have received any continuous or intermittent small molecule therapeutics (excluding monoclonal antibodies) =<  effective half lives prior to starting study drug or who have not recovered from side effects of such therapy
Patients who have received any continuous or intermittent small molecule therapeutics (excluding monoclonal antibodies) =<  effective half-lives prior to starting study drug or who have not recovered from side effects of such therapy
Patients who have received any continuous or intermittent small molecule therapeutics (excluding monoclonal antibodies) =<  weeks (or =<  weeks for a monoclonal antibody) prior to starting study drug or who have not recovered from side effects of such therapy
Patients who have received any continuous or intermittent small molecule therapeutics (excluding monoclonal antibodies) =<  effective half lives prior to starting study drug or who have not recovered from side effects of such therapy
Patients who have received any continuous or intermittent small molecule therapeutics (excluding monoclonal antibodies) =<  effective half-lives prior to starting study drug or who have not recovered from side effects of such therapy
Any continuous or intermittent small molecule therapeutics (excluding monoclonal antibodies) =<  effective half-lives prior to starting study drug or patients who have not recovered from side effects of such therapy
Patients who have received any continuous or intermittent small molecule therapeutics (excluding monoclonal antibodies) =<  effective half lives prior to starting study drug or who have not recovered from side effects of such therapy (except alopecia)